Serum survivin and vascular endothelial growth factor in extranodal NK/T-cell lymphoma, nasal type: implications for a potential new prognostic indicator

• Seok Jin Kim,
• Mineui Hong,
• In-Gu Do,
• Seung Ho Lee,
• Kyung Ju Ryu,
• Hae Yong Yoo,
• Jung Yong Hong,
• Young Hyeh Ko,
• Won Seog Kim

Affiliations

Seok Jin Kim

Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea

Mineui Hong

Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea

In-Gu Do

Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea

Seung Ho Lee

Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Korea

Kyung Ju Ryu

Samsung Biomedical Research Institute, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea

Hae Yong Yoo

Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Korea;Samsung Biomedical Research Institute, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea

Jung Yong Hong

Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea

Young Hyeh Ko

Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea

Won Seog Kim

Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea